Report error Found 72 Enz. Inhib. hit(s) with all data for entry = 6769
Affinity DataIC50: 430nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
3D Structure (crystal)
Affinity DataIC50: 650nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+3nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMAssay Description:One potential limitation of the above FP assay is the risk of selection of compounds that may interfere with the FP assays and produce so called fals...More data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+3nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 2.40E+3nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 3.80E+3nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 4.40E+3nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 4.60E+3nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 4.80E+3nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 6.30E+3nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 7.00E+3nMAssay Description:One potential limitation of the above FP assay is the risk of selection of compounds that may interfere with the FP assays and produce so called fals...More data for this Ligand-Target Pair
Affinity DataIC50: 7.00E+3nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 7.40E+3nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 8.70E+3nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+4nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+4nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+4nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+4nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+4nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+4nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 2.70E+4nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 2.80E+4nMAssay Description:One potential limitation of the above FP assay is the risk of selection of compounds that may interfere with the FP assays and produce so called fals...More data for this Ligand-Target Pair
Affinity DataIC50: 2.90E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 2.95E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+4nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 3.20E+4nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 3.30E+4nMAssay Description:One potential limitation of the above FP assay is the risk of selection of compounds that may interfere with the FP assays and produce so called fals...More data for this Ligand-Target Pair
Affinity DataIC50: 3.50E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 3.50E+4nMAssay Description:One potential limitation of the above FP assay is the risk of selection of compounds that may interfere with the FP assays and produce so called fals...More data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+4nMAssay Description:NMR spectroscopy validation of lead compounds. In embodiments of the present invention, and during development thereof, NMR spectroscopy: saturation ...More data for this Ligand-Target Pair
Affinity DataIC50: 4.20E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 4.90E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 6.00E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 6.30E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 6.70E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 7.10E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 7.20E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 8.00E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 8.30E+4nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
Affinity DataIC50: 8.50E+4nMAssay Description:One potential limitation of the above FP assay is the risk of selection of compounds that may interfere with the FP assays and produce so called fals...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Assays effective in monitoring the inhibition of the MLL binding to menin were developed during experiments performed during the development of embod...More data for this Ligand-Target Pair
